George Annas, "Zika: Public Health (and Safety) Emergencies"

•

1 like•407 views

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

January 23, 2017 The Fifth Annual Health Law Year in P/Review symposium featured leading experts discussing major developments during 2016 and what to watch out for in 2017. The discussion at this day-long event covered hot topics in such areas as health policy under the new administration, regulatory issues in clinical research, law at the end-of-life, patient rights and advocacy, pharmaceutical policy, reproductive health, and public health law. The Fifth Annual Health Law Year in P/Review was sponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, Harvard Health Publications at Harvard Medical School, Health Affairs, the Hastings Center, the Program On Regulation, Therapeutics, And Law (PORTAL) in the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women’s Hospital, and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund. Learn more on our website: http://petrieflom.law.harvard.edu/events/details/5th-annual-health-law-year-in-p-review

Healthcare

Zika:
Public Health (and Safety) Emergencies
George J. Annas
Professor & Director, Center for Health
Law, Ethics & Human Rights
Boston University Schools of
Public Health, Medicine, and Law

by George Annas, Sandro Galea and
Donald Thea
BOSTON GLOBE, Feb. 1, 2016
“Zika virus is not Ebola”

“A Gold Medal in Fear
Mongering”
Galea, Thea & Annas
HUFFINGTON POST, June 2, 2016

Major Human Rights Documents
• Universal Declaration of Human Rights (UDHR)
• Geneva Conventions
• International Covenant Civil & Political Rights (ICCPR)
• International Covenant Economic, Social and Cultural
Rights (ICESCR)
• Convention and the Rights of the Child (CRC)
• Convention on the Elimination of Discrimination Against
Women (CEDAW)

• A “public health
emergency of
international concern”
(art. 12)
• “extraordinary event…risk of
international spread of
disease…potentially
requiring an international
response.”
The sovereign right [of each
state to legislate and implement
health policies shall be
respected]

• H1N1
(2009)
• Polio (2014)
• Ebola
(2014)
• Zika (2016)

Public Health Emergency
Responses
1. Prevention remains primary goal
(a) can’t make prevention efforts worse off;
(b) can’t create ‘worse’ viruses/infectious agents.
2. Government has Primary Responsibility (therefore must
follow basic human rights law, esp. nondiscrimination; right to
health; women & children).
3. Must be Sustainable; should contribute to building a health
care system and infrastructure, not silos.
4. No emergency exceptions to informed consent for
research. (including gene drives)

April 5, 2016 Panelists discussed the relationship between genetics, enhancement, public health, and national security. Speakers: - Jamie Metzl, "The National Security Implications of the Genetics Revolution" - George Annas, "Post-9/11 Uses of Public Health and Medicine by National Security Agencies" - Jonathan Moreno, "National Security and Biology" Cosponsored by the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School, the Harvard National Security & Law Association, the Harvard National Security Journal, and the Center for Bioethics at Harvard Medical School, with support from the Oswald DeN. Cammann Fund at Harvard University. Visit our website to learn more!: http://petrieflom.law.harvard.edu/events/details/the-national-security-implications-of-the-genetics-revolution

dicussion board responses.docx

sdfghj21

dicussion board responses.docx

4934bk

Yale Study: The United Nations' Responsibility for the Haitian Cholera Epidemic

Stanleylucas

This report addresses the responsibility of the United Nations (U.N.) for the cholera epidemic in Haiti—one of the largest cholera epidemics in modern history. The report provides a comprehensive analysis of the evidence that the U.N. brought cholera to Haiti, relevant international legal and humanitarian standards necessary to understand U.N. accountability, and steps that the U.N. and other key national and international actors must take to rectify this harm. Despite overwhelming evidence linking the U.N. Mission for the Stabilization in Haiti (MINUSTAH)1 to the outbreak, the U.N. has denied responsibility for causing the epidemic. The organization has refused to adjudicate legal claims from cholera victims or to otherwise remedy the harms they have suffered. By causing the epidemic and then refusing to provide redress to those affected, the U.N. has breached its commitments to the Government of Haiti, its obligations under international law, and principles of humanitarian relief. Now, nearly four years after the epidemic began, the U.N. is leading efforts to eliminate cholera but has still not taken responsibility for its own actions. As new infections continue to mount, accountability for the U.N.’s failures in Haiti is as important as ever.

public Health Communications and AdvocacyMuhammad Bilal Saleem

Public health and infectious disease

Carlos Amade

Rapport Yale University sur le Cholera des Nations Unies en Haiti

Stanleylucas

Le rapport établit la responsabilité des soldats Népalais de la mission des Nations Unies (MINUSTAH) qui ont amené la bactérie choléra en Haiti et a cause l'épidémie. L'épidémie de la MINUSTAH a tuée plus de 7500 Haïtiens et contaminée près de 800.000. Jusqu'a présent les Nations Unies malgré les preuves scientifiques refusent d'admettre leur responsabilité. Les Haïtiens vont se battre jusqu'a ce que cette injustice soit réparée.

Viewers also liked

Ty Resume - 07122016Ty Specht

Proyecto de vida vane

vanedelcastillo

Методы прогнозирования основных экономических показателей ап

nizhgma.ru

The Business CycleMrRed

Cuestionario planeacion estrategica.

VICTORQQTA1993

ATC Transponder Systems Mode A Replies

lisalouisesw

Viewers also liked (6)

Ty Resume - 07122016

Proyecto de vida vane

Методы прогнозирования основных экономических показателей ап

The Business Cycle

Cuestionario planeacion estrategica.

ATC Transponder Systems Mode A Replies

Similar to George Annas, "Zika: Public Health (and Safety) Emergencies"

Dr. dasen brajkovic md the public health

drdasenbrajkovicmd

Stienstra - Cooperation in public health good for global economy

Stef Stienstra

COVID.City.Tuskegee.Bootstraps.TALK.5.17.2022.Alexander.final.1.pptx

WeldonFultz1

The Role of Public Health in America

Regan Orman

15 Role of epidemiology in public health

Abdiwali Abdullahi Abdiwali

Alistair de Gaetano: The Autism Genome Project and Genocide: The Unbearable U...

Beitissie1

INTG Project (1)Melissa Arrendell

CGI Newsletter 26 October 2014

Dr. Chris Stout

Globalization and public health

ImroseRashid

George Annas, Post-9/11 Uses of Public Health and Medicine for National Security

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

dicussion board responses.docx

sdfghj21

dicussion board responses.docx

4934bk

Yale Study: The United Nations' Responsibility for the Haitian Cholera Epidemic

Stanleylucas

public Health Communications and AdvocacyMuhammad Bilal Saleem

Public health and infectious disease

Carlos Amade

Rapport Yale University sur le Cholera des Nations Unies en Haiti

Stanleylucas

What is global health? Dr Slim Slama, Geneva University HospitalsGeneva Health Forum

Catholic Distance University Humanitarian Emergency Paper.docx

write12

Catholic Distance University Humanitarian Emergency Paper.docx

sdfghj21

Bioterrorism CIIT ATD sp13-bty-001

Zohaib HUSSAIN

Bioterrorism Introduction Bioterrorism is the intentional or threatened use of viruses, bacteria, fungi, or toxins from living organisms to produce death or disease in humans, animals or plants to accomplish political or social objectives. Agents of bioterrorism can be altered or mutated in such a way soas to increase their virulence and ability to cause disease. They can be engineered to resist current medications. They can be spread through air, food, water, fomites, or through infected hosts (including humans, animals, insects, and other reservoirs)

Similar to George Annas, "Zika: Public Health (and Safety) Emergencies" (20)

Dr. dasen brajkovic md the public health

Stienstra - Cooperation in public health good for global economy

COVID.City.Tuskegee.Bootstraps.TALK.5.17.2022.Alexander.final.1.pptx

The Role of Public Health in America

15 Role of epidemiology in public health

Alistair de Gaetano: The Autism Genome Project and Genocide: The Unbearable U...

INTG Project (1)

CGI Newsletter 26 October 2014

Globalization and public health

George Annas, Post-9/11 Uses of Public Health and Medicine for National Security

dicussion board responses.docx

Yale Study: The United Nations' Responsibility for the Haitian Cholera Epidemic

public Health Communications and Advocacy

Public health and infectious disease

Rapport Yale University sur le Cholera des Nations Unies en Haiti

What is global health? Dr Slim Slama, Geneva University Hospitals

Catholic Distance University Humanitarian Emergency Paper.docx

Bioterrorism CIIT ATD sp13-bty-001

More from The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Christine Mitchell, Ethical Dilemmas in Mask and Equipment Shortages: Health ...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Personal protective equipment or PPE has been a major topic of discussion across the nation. The COVID-19 pandemic has exposed major shortages of PPE and health care workers are being asked take care of patients with what some would argue is inadequate protection. The guidelines set by the CDC have changed and recommendations have even gone so far as to approve bandannas as a means for respiratory protection. Some have argued that it is unethical for health care workers to not have adequate protection, while others think it's their duty, protected or not. Adding to this debate has been theft, hoarding and disparate distribution of these critical supplies. During this panel discussion moderator Carmel Shachar, Stephen P. Wood, Christine Mitchell and Dr. Michael Mina explored the ethics of PPE in the COVID-19 pandemic.

Robert Yates, "Hospital Detentions For Non-Payment of Fees A Denial of Rights...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

March 27, 2020 Each year in low- and middle-income countries thousands of people are detained in hospitals for non-payment of medical bills, despite the fact that such detention is a violation of national and international law. Hospital detention for nonpayment of bills disproportionately affects the most vulnerable people, including post-partum women. In the US, medical debt manifests itself in other ways, including bankruptcy, litigation to garnish wages, and foregone care. In both contexts, these scandals are the result of failures of financing, priority-setting, and legal oversight. Without addressing these systemic issues, a "human right to health care" will remain a hollow slogan, as will political promises to achieve universal health coverage. This event will feature Robert Yates of Chatham House, which has conducted an in-depth investigation of the global phenomenon of hospital detentions. Additional panelists will address manifestations of predatory lending and surprise medical fees in the United States, the ethical imperatives of financing and priority setting for UHC in general, and the implications for thinking about health care as a human right. For more information, visit our website at: https://petrieflom.law.harvard.edu/events/details/debt-dignity-and-health-care

Ranak Trivedi, "Bridging the Gap Between Artificial Intelligence and Natural ...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

March 24, 2020 This event will highlight the challenges and opportunities in harnessing artificial intelligence (AI) technologies to serve the needs of individuals with disabilities and dependencies. AI can improve the lives of people with disabilities, such as smart devices supporting people with physical disabilities or sight loss. On the other hand, AI outputs can also reflect discriminatory biases present in the underlying data used to develop the algorithms. While this “garbage in, garbage out” principle is well documented in respect to AI and gender or race, it is understudied in respect to disability or dependencies. Interdisciplinary panels of legal scholars, ethicists, AI developers, medical and service providers, and advocates with disabilities/ dependencies will explore best practices and guidelines for stakeholders, guided by ethical principles, legal considerations, and the needs of people with disabilities/ dependencies. Participants will seek to articulate clear criteria for developers and medical providers looking to harness the potential of AI to serve individuals with disabilities/ dependencies, including those whose disabilities/ dependencies are the result of aging, injury, or disease, and the caregivers -- including both professionals and unpaid friends and families -- who support some of these individuals. This webinar was free and open the public. For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/artificial-intelligence-and-disability-dependency

Noll Campbell,"Artificial Intelligence & Disabilities: Cognitive Impairment a...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Emily M. Broad Leib, Policies to Reduce Sugar Consumption: The Battleground

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

February 14, 2020 On February 14, 2020, Harvard Medical School Center for Bioethics and the Program on Regulation, Therapeutics, and Law (PORTAL) at Brigham and Women's Hospital, in collaboration with the Petrie-Flom Center hosted the monthly health policy consortium on sugar-sweetened beverage excise taxes. In recent years, some cities have tried to impose soda taxes and other new policies to reduce the obesity epidemic in the US—particularly among children—and its critical impact on society and the health care system. How effective are these policies? What is blocking their uptake? What alternatives should we consider? For more information visit our website at: https://petrieflom.law.harvard.edu/events/details/soda-taxes-and-other-policy-responses-to-the-american-obesity-epidemic

Steven Gortmaker, Sugar Sweetened Beverage Taxes: Impact on Health, Health Ca...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Justin T. Baker, Into the Deep

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

October 23, 2019 The future of neuroscience and law will be a computational future, as both fields are increasingly integrating artificial intelligence and machine learning. But what will this future look like? Can AI and digital technologies promote justice, diversity, and inclusion? Or will these technologies replicate, or even exacerbate, existing inequalities and biases? In this lunchtime event, leading experts in artificial intelligence, computational psychiatry, and the law discussed these questions as they explored how AI and digital technologies can advance social good through improved social, psychiatric, and legal interventions. For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/computational-justice

Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons ...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

October 7, 2019 On October 7, 2019, the Harvard Global Health Institute will host a one-day symposium to explore what enabled this visionary program, and to showcase how it has transformed not just the worldwide HIV/AIDS response but global health delivery more broadly. There are many lessons learned in PEPFAR’s story - from what it took to build a supply chain where there was none, to establishing the use of generic antiretroviral therapies (ARTs) and leveraging human capacity. This event convened the early architects of PEPFAR as well as experts and implementers currently leading the charge. We took a historically informed look at what it will take to stop global transmission, and shared tools useful for others hoping to move the needle on vexing problems in global health. For more information, visit our website at https://petrieflom.law.harvard.edu/events/details/15-years-of-pepfar

Prosper Okonkwo, 15+ Years of PEPFAR - The Nigeria Experience

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Maureen Luba Milambe, A 15 Year Review of PEPFAR Support to Malawi: How Has i...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Phyllis J. Kanki, 15+ Years of PEPFAR: Getting to Zero

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Shahin Lockman, Botswana: Arc of and Response to the HIV Epidemic

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Charles Holmes, 2009-2013 From an Emergency Response to Local Ownership and S...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Anthony S. Fauci, The Birth of PEPFAR

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Dov Fox, "Birth Rights & Wrongs: How Medicine and Technology Are Remaking Rep...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

September 10, 2019 Book Talk: Birth Rights and Wrongs: How Medicine and Technology are Remaking Reproduction and the Law Millions of Americans rely on the likes of birth control, IVF, and genetic testing to make plans as intimate and far-reaching as any over a lifetime. This is no less than the medicine of miracles. It fills empty cradles, frees families from terrible disease, and empowers them to fashion their lives on their own terms. But accidents happen. Pharmacists mix up pills. Lab techs misread tests. Obstetricians tell women their healthy fetuses would be stillborn. Political and economic forces conspire against regulation. And judges throw up their hands when professionals foist parenthood on people who didn't want it, or childlessness on those who did. Failed abortions, switched donors, and lost embryos may be first-world problems. But these aren't innocent lapses or harmless errors. They're wrongs in need of rights. At this event, author Dov Fox and an expert panel discussed his book Birth Rights and Wrongs: How Medicine and Technology are Remaking Reproduction and the Law (Oxford University Press, 2019). Panelists explored the ways in which the book seeks to lift the curtain on reproductive negligence, give voice to the lives it upends, and vindicate the interests that advances in medicine and technology bring to full expression. They also examined the book's effort to force citizens and courts to rethink the reproductive controversies of our time, and to equip us to meet the new challenges -- from womb transplants to gene editing -- that lie just over the horizon. Learn more: https://petrieflom.law.harvard.edu/events/details/book-talk-birth-rights-and-wrongs

Katherine L. Kraschel, "What Doesn't Kill Your Tort Only Makes It Stronger --...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

Vardit Ravitsky, "Prenatal Genome Sequencing: Ethical and Regulatory Implicat...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

May 17, 2019 Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing. As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics. Presentation: Vardit Ravitsky, Associate Professor, Bioethics Programs, Department of Social and Preventive Medicine, School of Public Health, University of Montreal; Director, Ethics and Health Branch, Center for Research on Ethics - Prenatal Genome Sequencing: Ethical and Regulatory Implications for Post-Birth Access to Information Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference

Liza Vertinsky, "Genetic Paparazzi vs. Genetic Privacy"

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

May 17, 2019 Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing. As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics. Presentation: Liza Vertinsky, Associate Professor of Law, Emory University School of Law and Emory Global Health Institute Faculty Fellow (with Yaniv Heled) - Genetic Privacy and Public Figures Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference

Scott Schweikart, "Human Genome Editing: An Ethical Analysis and Arguments fo...

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

May 17, 2019 Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing. As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics. Presentation: Scott Schweikart, Senior Research Associate, Council on Ethical and Judicial Affairs, American Medical Association and Legal Editor, AMA Journal of Ethics - Human Gene Editing: An Ethical Analysis and Arguments for Regulatory Guidance at Both the National and Global Levels Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference

Emily Qian, "Physician-Mediated Elective Whole Genome Sequencing Tests"

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

May 17, 2019 Breakthroughs in genetics have often raised complex ethical and legal questions, which loom ever larger as genetic testing is becoming more commonplace, affordable, and comprehensive and genetic editing becomes poised to be a consumer technology. As genetic technologies become more accessible to individuals, the ethical and legal questions around the consumer use of these technologies become more pressing. As these questions become more pressing, now is the time to re-consider what ethical and regulatory safeguards should be implemented and discuss the many questions raised by advancements in consumer genetics. Presentation: Emily Qian, Genetic Counselor, Veritas Genetics (with Magalie Leduc, Rebecca Hodges, Bryan Cosca, Ryan Durigan, Laurie McCright, Doug Flood, and Birgit Funke) - Physician-Mediated Elective Whole Genome Sequencing Tests: Impacts on Informed Consent Learn more: https://petrieflom.law.harvard.edu/events/details/2019-petrie-flom-center-annual-conference

More from The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics (20)

Christine Mitchell, Ethical Dilemmas in Mask and Equipment Shortages: Health ...

Robert Yates, "Hospital Detentions For Non-Payment of Fees A Denial of Rights...

Ranak Trivedi, "Bridging the Gap Between Artificial Intelligence and Natural ...

Noll Campbell,"Artificial Intelligence & Disabilities: Cognitive Impairment a...

Emily M. Broad Leib, Policies to Reduce Sugar Consumption: The Battleground

Steven Gortmaker, Sugar Sweetened Beverage Taxes: Impact on Health, Health Ca...

Justin T. Baker, Into the Deep

Nzovu Ulenga, Tanzania HIV/AIDS Progress: Successes, Challenges, and Lessons ...

Prosper Okonkwo, 15+ Years of PEPFAR - The Nigeria Experience

Maureen Luba Milambe, A 15 Year Review of PEPFAR Support to Malawi: How Has i...

Phyllis J. Kanki, 15+ Years of PEPFAR: Getting to Zero

Shahin Lockman, Botswana: Arc of and Response to the HIV Epidemic

Charles Holmes, 2009-2013 From an Emergency Response to Local Ownership and S...

Anthony S. Fauci, The Birth of PEPFAR

Dov Fox, "Birth Rights & Wrongs: How Medicine and Technology Are Remaking Rep...

Katherine L. Kraschel, "What Doesn't Kill Your Tort Only Makes It Stronger --...

Vardit Ravitsky, "Prenatal Genome Sequencing: Ethical and Regulatory Implicat...

Liza Vertinsky, "Genetic Paparazzi vs. Genetic Privacy"

Scott Schweikart, "Human Genome Editing: An Ethical Analysis and Arguments fo...

Emily Qian, "Physician-Mediated Elective Whole Genome Sequencing Tests"

Recently uploaded

.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD

samahesh1

Telehealth Psychology Building Trust with Clients.pptx

The Harvest Clinic

Neuro Saphirex Cranial Brochure

RXOOM Healthcare Pvt. Ltd.

Roti bank chennai PPT [Autosaved].pptx1

roti bank

Nursing Care of Client With Acute And Chronic Renal Failure.ppt

Rommel Luis III Israel

CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf

Sachin Sharma

This content provides an overview of preventive pediatrics. It defines preventive pediatrics as preventing disease and promoting children's physical, mental, and social well-being to achieve positive health. It discusses antenatal, postnatal, and social preventive pediatrics. It also covers various child health programs like immunization, breastfeeding, ICDS, and the roles of organizations like WHO, UNICEF, and nurses in preventive pediatrics.

Navigating Challenges: Mental Health, Legislation, and the Prison System in B...

Guillermo Rivera

This conference will delve into the intricate intersections between mental health, legal frameworks, and the prison system in Bolivia. It aims to provide a comprehensive overview of the current challenges faced by mental health professionals working within the legislative and correctional landscapes. Topics of discussion will include the prevalence and impact of mental health issues among the incarcerated population, the effectiveness of existing mental health policies and legislation, and potential reforms to enhance the mental health support system within prisons.

Dimensions of Healthcare Quality

Naeemshahzad51

The dimensions of healthcare quality refer to various attributes or aspects that define the standard of healthcare services. These dimensions are used to evaluate, measure, and improve the quality of care provided to patients. A comprehensive understanding of these dimensions ensures that healthcare systems can address various aspects of patient care effectively and holistically. Dimensions of Healthcare Quality and Performance of care include the following; Appropriateness, Availability, Competence, Continuity, Effectiveness, Efficiency, Efficacy, Prevention, Respect and Care, Safety as well as Timeliness.

CONSTRUCTION OF TEST IN MANAGEMENT .docx

PGIMS Rohtak

Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE

ranishasharma67

Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond

Health Catalyst

Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs). In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.

POLYCYSTIC OVARIAN SYNDROME (PCOS)......

Ameena Kadar

Introduction to Forensic Pathology course

fprxsqvnz5

Antibiotic Stewardship by Anushri Srivastava.pptx

AnushriSrivastav

Stewardship is the act of taking good care of something. Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms. WHO launched the Global Antimicrobial Resistance and Use Surveillance System (GLASS) in 2015 to fill knowledge gaps and inform strategies at all levels. ACCORDING TO apic.org, Antimicrobial stewardship is a coordinated program that promotes the appropriate use of antimicrobials (including antibiotics), improves patient outcomes, reduces microbial resistance, and decreases the spread of infections caused by multidrug-resistant organisms. ACCORDING TO pewtrusts.org, Antibiotic stewardship refers to efforts in doctors’ offices, hospitals, long term care facilities, and other health care settings to ensure that antibiotics are used only when necessary and appropriate According to WHO, Antimicrobial stewardship is a systematic approach to educate and support health care professionals to follow evidence-based guidelines for prescribing and administering antimicrobials In 1996, John McGowan and Dale Gerding first applied the term antimicrobial stewardship, where they suggested a causal association between antimicrobial agent use and resistance. They also focused on the urgency of large-scale controlled trials of antimicrobial-use regulation employing sophisticated epidemiologic methods, molecular typing, and precise resistance mechanism analysis. Antimicrobial Stewardship(AMS) refers to the optimal selection, dosing, and duration of antimicrobial treatment resulting in the best clinical outcome with minimal side effects to the patients and minimal impact on subsequent resistance. According to the 2019 report, in the US, more than 2.8 million antibiotic-resistant infections occur each year, and more than 35000 people die. In addition to this, it also mentioned that 223,900 cases of Clostridoides difficile occurred in 2017, of which 12800 people died. The report did not include viruses or parasites VISION Being proactive Supporting optimal animal and human health Exploring ways to reduce overall use of antimicrobials Using the drugs that prevent and treat disease by killing microscopic organisms in a responsible way GOAL to prevent the generation and spread of antimicrobial resistance (AMR). Doing so will preserve the effectiveness of these drugs in animals and humans for years to come. being to preserve human and animal health and the effectiveness of antimicrobial medications. to implement a multidisciplinary approach in assembling a stewardship team to include an infectious disease physician, a clinical pharmacist with infectious diseases training, infection preventionist, and a close collaboration with the staff in the clinical microbiology laboratory to prevent antimicrobial overuse, misuse and abuse. to minimize the developme

VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...

rajkumar669520

Yemen National Tuberculosis Program .ppt

Esam43

Medical Technology Tackles New Health Care Demand - Research Report - March 2...

pchutichetpong

M Capital Group (“MCG”) predicts that with, against, despite, and even without the global pandemic, the medical technology (MedTech) industry shows signs of continuous healthy growth, driven by smaller, faster, and cheaper devices, growing demand for home-based applications, technological innovation, strategic acquisitions, investments, and SPAC listings. MCG predicts that this should reflects itself in annual growth of over 6%, well beyond 2028. According to Chris Mouchabhani, Managing Partner at M Capital Group, “Despite all economic scenarios that one may consider, beyond overall economic shocks, medical technology should remain one of the most promising and robust sectors over the short to medium term and well beyond 2028.” There is a movement towards home-based care for the elderly, next generation scanning and MRI devices, wearable technology, artificial intelligence incorporation, and online connectivity. Experts also see a focus on predictive, preventive, personalized, participatory, and precision medicine, with rising levels of integration of home care and technological innovation. The average cost of treatment has been rising across the board, creating additional financial burdens to governments, healthcare providers and insurance companies. According to MCG, cost-per-inpatient-stay in the United States alone rose on average annually by over 13% between 2014 to 2021, leading MedTech to focus research efforts on optimized medical equipment at lower price points, whilst emphasizing portability and ease of use. Namely, 46% of the 1,008 medical technology companies in the 2021 MedTech Innovator (“MTI”) database are focusing on prevention, wellness, detection, or diagnosis, signaling a clear push for preventive care to also tackle costs. In addition, there has also been a lasting impact on consumer and medical demand for home care, supported by the pandemic. Lockdowns, closure of care facilities, and healthcare systems subjected to capacity pressure, accelerated demand away from traditional inpatient care. Now, outpatient care solutions are driving industry production, with nearly 70% of recent diagnostics start-up companies producing products in areas such as ambulatory clinics, at-home care, and self-administered diagnostics.

HEAT WAVE presented by priya bhojwani..pptx

priyabhojwani1200

Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...

The Lifesciences Magazine

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx

R3 Stem Cell

Recently uploaded (20)

.Metabolic.disordersYYSSSFFSSSSSSSSSSDDD

Telehealth Psychology Building Trust with Clients.pptx

Neuro Saphirex Cranial Brochure

Roti bank chennai PPT [Autosaved].pptx1

Nursing Care of Client With Acute And Chronic Renal Failure.ppt

CHAPTER 1 SEMESTER V PREVENTIVE-PEDIATRICS.pdf

Navigating Challenges: Mental Health, Legislation, and the Prison System in B...

Dimensions of Healthcare Quality

CONSTRUCTION OF TEST IN MANAGEMENT .docx

Jaipur ❤cALL gIRLS 89O1183002 ❤ℂall Girls IN JaiPuR ESCORT SERVICE

Empowering ACOs: Leveraging Quality Management Tools for MIPS and Beyond

POLYCYSTIC OVARIAN SYNDROME (PCOS)......

Introduction to Forensic Pathology course

Antibiotic Stewardship by Anushri Srivastava.pptx

VVIP Dehradun Girls 9719300533 Heat-bake { Dehradun } Genteel ℂall Serviℂe By...

Yemen National Tuberculosis Program .ppt

Medical Technology Tackles New Health Care Demand - Research Report - March 2...

HEAT WAVE presented by priya bhojwani..pptx

Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...

R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptx

George Annas, "Zika: Public Health (and Safety) Emergencies"

1. Zika: Public Health (and Safety) Emergencies George J. Annas Professor & Director, Center for Health Law, Ethics & Human Rights Boston University Schools of Public Health, Medicine, and Law

5. by George Annas, Sandro Galea and Donald Thea BOSTON GLOBE, Feb. 1, 2016 “Zika virus is not Ebola”

9. “A Gold Medal in Fear Mongering” Galea, Thea & Annas HUFFINGTON POST, June 2, 2016

10. Major Human Rights Documents • Universal Declaration of Human Rights (UDHR) • Geneva Conventions • International Covenant Civil & Political Rights (ICCPR) • International Covenant Economic, Social and Cultural Rights (ICESCR) • Convention and the Rights of the Child (CRC) • Convention on the Elimination of Discrimination Against Women (CEDAW)

11.

12. • America First • Seal the Borders

13.

14. • A “public health emergency of international concern” (art. 12) • “extraordinary event…risk of international spread of disease…potentially requiring an international response.” The sovereign right [of each state to legislate and implement health policies shall be respected]

15. • H1N1 (2009) • Polio (2014) • Ebola (2014) • Zika (2016)

16. Public Health Emergency Responses 1. Prevention remains primary goal (a) can’t make prevention efforts worse off; (b) can’t create ‘worse’ viruses/infectious agents. 2. Government has Primary Responsibility (therefore must follow basic human rights law, esp. nondiscrimination; right to health; women & children). 3. Must be Sustainable; should contribute to building a health care system and infrastructure, not silos. 4. No emergency exceptions to informed consent for research. (including gene drives)

George Annas, "Zika: Public Health (and Safety) Emergencies"

Recommended

Recommended

More Related Content

Viewers also liked

Viewers also liked (6)

Similar to George Annas, "Zika: Public Health (and Safety) Emergencies"

Similar to George Annas, "Zika: Public Health (and Safety) Emergencies" (20)

More from The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics

More from The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics (20)

Recently uploaded

Recently uploaded (20)

George Annas, "Zika: Public Health (and Safety) Emergencies"